Literature DB >> 16712855

Endothelial function and arterial stiffness in sickle-thalassemia patients.

Athanasios Aessopos1, Dimitrios Farmakis, Maria Tsironi, Evanthia Diamanti-Kandarakis, Marina Matzourani, Christina Fragodimiri, Antonia Hatziliami, Markisia Karagiorga.   

Abstract

BACKGROUND: Homozygous sickle-cell anemia and beta-thalassemia are characterized by impaired endothelial function, while data on arterial stiffness have hitherto been conflicting. We sought to investigate aortic elastic properties and endothelial function in sickle-thalassemia, which combines molecular and clinical features of the above conditions. METHODS AND
RESULTS: Forty-seven sickle-thalassemia patients, younger than 45 years, with preserved left ventricular (LV) function and no history of smoking, systemic or pulmonary hypertension, diabetes mellitus, dyslipidemia or thyroid disease, along with 40 healthy controls were studied. Aortic strain, distensibility and stiffness index were calculated by echocardiographically-obtained aortic root diameters. Brachial artery endothelial function was assessed by ultrasonographic evaluation of flow-mediated dilatation (FMD) and nitrate-mediated dilatation (NMD). Left ventricle was assessed by echocardiography. Patients had an impaired FMD (4.2+/-2.9% versus 9.2+/-3.8% in controls, p<0.001) with a preserved NMD (16.9+/-5.6% versus 15.2+/-4.8% in controls, p>0.05). Aortic strain and distensibility were lower and aortic stiffness index was higher in patients compared to controls (8.1+/-4.6 versus 5.8+/-2.9, p<0.01). Indexed LV diameters and mass were higher in patients. Systolic LV function was preserved, while 14.9% of patients had an impaired relaxation transmitral inflow pattern. Patients' LV mass index and diastolic mitral E wave deceleration time were positively correlated with aortic stiffness index (p<0.001).
CONCLUSION: Sickle-thalassemia is characterized by a complex vasculopathy, consisting of endothelial dysfunction and increased arterial stiffness, with a global effect on cardiovascular function.

Entities:  

Mesh:

Year:  2006        PMID: 16712855     DOI: 10.1016/j.atherosclerosis.2006.04.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

1.  Abnormalities in aortic properties: a potential link between left ventricular diastolic function and ventricular-aortic coupling in sickle cell disease.

Authors:  Emilie Bollache; Nadjia Kachenoura; Roberto M Lang; Ankit A Desai; Victor Mor-Avi; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-23       Impact factor: 2.357

2.  Atherosclerosis in sickle cell disease - a review.

Authors:  Mohamed A Elsharawy; Khaled M Moghazy; Mohamed A Shawarby
Journal:  Int J Angiol       Date:  2009

3.  Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy.

Authors:  Ashlee N Higdon; Gloria A Benavides; Balu K Chacko; Xiaosen Ouyang; Michelle S Johnson; Aimee Landar; Jianhua Zhang; Victor M Darley-Usmar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-13       Impact factor: 4.733

4.  Altered vascular function, arterial stiffness, and antioxidant gene responses in pediatric thalassemia patients.

Authors:  Pantipa Detchaporn; Upa Kukongviriyapan; Auemduan Prawan; Arunee Jetsrisuparb; Stephen E Greenwald; Veerapol Kukongviriyapan
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

5.  Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell disease.

Authors:  Melissa C Caughey; Alan L Hinderliter; Susan K Jones; Sanjeev P Shah; Kenneth I Ataga
Journal:  Am J Cardiol       Date:  2012-02-15       Impact factor: 2.778

6.  Impact of β-thalassemia trait carrier state on cardiovascular risk factors and metabolic profile in patients with newly diagnosed hypertension.

Authors:  A I Triantafyllou; G P Vyssoulis; E A Karpanou; P L Karkalousos; E A Triantafyllou; A Aessopos; D T Farmakis
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

7.  Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia.

Authors:  Veerapol Kukongviriyapan; Nuntiya Somparn; Laddawan Senggunprai; Auemduan Prawan; Upa Kukongviriyapan; Arunee Jetsrisuparb
Journal:  Pediatr Cardiol       Date:  2007-09-22       Impact factor: 1.655

8.  Increased Red Blood Cell Stiffness Increases Pulmonary Vascular Resistance and Pulmonary Arterial Pressure.

Authors:  David A Schreier; Omid Forouzan; Timothy A Hacker; John Sheehan; Naomi Chesler
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

9.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

10.  Unmasking hypertension in children and adolescents with sickle/beta-thalassemia.

Authors:  Stella Stabouli; Christina Antza; Eleni Papadopoulou; Aikaterini Teli; Vasilios Kotsis; Marina Economou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.